86 related articles for article (PubMed ID: 29424511)
1. [Breast Cancer Survival: Clinical andPathological Prognostic Factors Analysis].
Maffuz-Aziz A; Labastida-Almendaro S; Sherwell-Cabello S; RuvalcabaLimón E; Domínguez-Reyes CA; Tenorio-Torres JA; Rodríguez-Cuevas S
Ginecol Obstet Mex; 2016 Aug; 84(8):498-506. PubMed ID: 29424511
[TBL] [Abstract][Full Text] [Related]
2. A retrospective prognostic evaluation analysis using the 8th edition of the American Joint Committee on Cancer staging system for breast cancer.
Lee SB; Sohn G; Kim J; Chung IY; Lee JW; Kim HJ; Ko BS; Son BH; Ahn SH
Breast Cancer Res Treat; 2018 Jun; 169(2):257-266. PubMed ID: 29388016
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics and prognosis of different subtypes of breast cancer].
Yuan ZY; Wang SS; Zhu MQ; Zheng L; Luo WB; Zhou ZM; Guan ZZ
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):456-61. PubMed ID: 19024523
[TBL] [Abstract][Full Text] [Related]
4. The influences of peritumoral lymphatic invasion and vascular invasion on the survival and recurrence according to the molecular subtypes of breast cancer.
Hwang KT; Kim YA; Kim J; Chu AJ; Chang JH; Oh SW; Hwang KR; Chai YJ
Breast Cancer Res Treat; 2017 May; 163(1):71-82. PubMed ID: 28194538
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors affecting disease-free survival in patients at age 35 or younger with invasive breast cancer.
Koca B; Kuru B; Karabicak I; Yürüker SS; Ozen N
Ann Ital Chir; 2014; 85(3):249-53. PubMed ID: 25074433
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
7. Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients.
Goorts B; van Nijnatten TJ; de Munck L; Moossdorff M; Heuts EM; de Boer M; Lobbes MB; Smidt ML
Breast Cancer Res Treat; 2017 May; 163(1):83-91. PubMed ID: 28205044
[TBL] [Abstract][Full Text] [Related]
8. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
[TBL] [Abstract][Full Text] [Related]
9. Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China.
Tang LC; Jin X; Yang HY; He M; Chang H; Shao ZM; Di GH
BMC Cancer; 2015 Mar; 15():201. PubMed ID: 25885213
[TBL] [Abstract][Full Text] [Related]
10. Young age and pathological features predict breast cancer outcome - report from a dual Institution experience in Serbia.
Cvetanovic A; Popovic L; Filipovic S; Trifunovic J; Zivkovic N; Matovina-Brko G; Kostic M; Vicko F; Kocic B; Kolarov-Bjelobrk I
J BUON; 2015; 20(6):1407-13. PubMed ID: 26854434
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics, diagnosis, and prognosis of pregnancy-associated breast cancer.
Wang B; Yang Y; Jiang Z; Zhao J; Mao Y; Liu J; Zhang J
Thorac Cancer; 2019 May; 10(5):1060-1068. PubMed ID: 30920126
[TBL] [Abstract][Full Text] [Related]
12. [Different influence of Her-2 expression on the prognosis in node-positive and node-negative breast cancer].
Wang Y; Yao L; Liu YQ; Xu Y; Ou YT; Li JF; Wang TF; Fan ZQ; Fan T; Lin BY; Xie YT
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):511-4. PubMed ID: 21029694
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features and prognosis analysis of different breast cancer molecular subtypes].
Yang Q; Chen J; Li HJ; Yu M; Tian CX; Lü Q
Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):42-6. PubMed ID: 21575463
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes in stage IIIB breast cancer patients who achieved less than a pathological complete response (Ionta MT; Atzori F; Deidda MC; Pusceddu V; Palmeri S; Frau B; Murgia M; Barca M; Minerba L; Massidda B
Oncologist; 2009 Nov; 14(11):1051-60. PubMed ID: 19897535
[TBL] [Abstract][Full Text] [Related]
15. Could Patients Older than 75 Years Benefit from a Systematic Breast Cancer Screening Program?
Ilenko A; Sergent F; Mercuzot A; Zitoun M; Chauffert B; Foulon A; Gondry J; Chevreau J
Anticancer Res; 2017 Feb; 37(2):903-907. PubMed ID: 28179350
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of molecular subtypes and prognosis of invasive breast cancer in north-east of Morocco: retrospective study.
Bennis S; Abbass F; Akasbi Y; Znati K; Joutei KA; El Mesbahi O; Amarti A
BMC Res Notes; 2012 Aug; 5():436. PubMed ID: 22889054
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of anatomic and prognostic stages of breast cancer according to the 8th edition of the TNM staging system - Retrospective analysis based on data from deceased patients once diagnosed with breast cancer].
Zombori T; Lehóczky L; Cserni B; Nyári T; Cserni G
Orv Hetil; 2017 Sep; 158(35):1373-1381. PubMed ID: 28847177
[TBL] [Abstract][Full Text] [Related]
18. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Value of the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging System in HER2-Enriched Subtype Breast Cancer, a Retrospective Analysis.
Zhou B; Xu L; Ye J; Xin L; Duan X; Liu Y
Anticancer Res; 2017 Aug; 37(8):4615-4621. PubMed ID: 28739761
[TBL] [Abstract][Full Text] [Related]
20. Risk for distant recurrence of breast cancer detected by mammography screening or other methods.
Joensuu H; Lehtimäki T; Holli K; Elomaa L; Turpeenniemi-Hujanen T; Kataja V; Anttila A; Lundin M; Isola J; Lundin J
JAMA; 2004 Sep; 292(9):1064-73. PubMed ID: 15339900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
